Autonomics Flashcards

1
Q

Ibuprofen: Brand name

A

Motrin; related naproxen (Aleve)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Ibuprofen: Drug Class (6)

A

Pharmacologic–NSAID

Therapeutic–analgesic, antipyretic, anti-inflammatory, anti-gout, anti-dysmennorhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ibuprofen: Pharmacodynamics

A

Exact mechanism unclear, but most likely involves inhibition of prostaglandin synthesis via COX 1 and COX 2 (effects on pain, inflammation, kidney, stomach)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ibuprofen: Pharmacokinetics (4)

A

F=80%
Extensive metabolism in liver
Some is excreted unchanged in urine
Half-life about 2-4 h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ibuprofen: Toxicity issues (contraindications, precautions, warnings, ADRs, etc) (3)

A

Avoid in patients “allergic” to aspirin (asthma, nasal polyps, etc)
Use with caution in patients with renal compromise or ulcer disease
Fluid retention in CHF patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ibuprofen: Drug interactions (4)

A

Warfarin
Aspirin
Diuretics
Antihypertensives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ibuprofen: Special considerations

A

Greater potential for toxicity in geriatric patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ibuprofen: Dose/route (not necessary to know)

A

OTC 200-400 mg po q4h prn pain; higher doses by prescription only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Norepinephrine: Brand name (2)

A

Noradrenaline, Levophed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Norepinephrine: Drug class (3)

A

Pharmacologic class—direct-acting adrenergic agonist

Therapeutic class —vasopressor, vasoconstrictor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Norepinephrine: Pharmacodynamics (4)

A

Major action is to stimulate peripheral alpha-1 adrenoceptors –> vasoconstriction (resistance arterioles, increase SVR) and venoconstriction (in capacitance vessels, increase preload)

  • -> Increases CO, SVR, and MAP
  • -> Decreases blood flow to vulnerable tissues like skin, muscle, and kidney
  • -> Stimulates beta-1 receptors in the heart, increasing HR and contractility; main effects are vasoconstriction and cardiac stimulation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Norepinephrine: Pharmacokinetics (6)

A

F ~100%
Given IV only
Metabolized by COMT and MAO, mostly in liver
Metabolites are excreted in urine
Half-life 1-2 minutes (e.g. can be titrated quickly IV)
Can cross the placenta, but not the blood/brain barrier.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Norepinephrine: Toxicity issues (contraindications, precautions, warnings, ADRs, etc) (2)

A

Excessive vasoconstriction in mesenteric vessels, peripheral arterioles causing ischemia, infarction, gangrene
Reflex bradycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Norepinephrine: Drug interactions (2)

A

Use cautiously in patients taking an MAO inhibitor such as phenelzine (use lower doses)
Risk of excessive hypertension in patients taking propranolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Norepinephrine: Special considerations (4)

A

Correct volume depletion with IV fluids BEFORE giving NE infusion
Select infusion site carefully—extravasation is a major problem
Monitor patient and BP continuously in ICU setting
Use cautiously in pediatric and geriatric patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Norepinephrine: Dose/route (not necessary to know)

A

For adults with acute hypotension and shock (related to low SVR) infuse 2-12 mcg/min

17
Q

Norepinephrine: Monitor (4)

A

BP, HR, infusion site, evidence of extravasation

18
Q

Epinephrine: Brand name

A

Adrenaline, EpiPen

19
Q

Epinephrine: Drug class

A

Pharmacologic class—direct-acting adrenergic agonist
Therapeutic class—vasopressor, cardiac stimulant, bronchodilator, adjunct to local anesthetics, treatment for anaphylaxis

20
Q

Epinephrine: Pharmacodynamics

A

Major action is to stimulate peripheral alpha-1 adrenoceptors, thereby leading to vasoconstriction (resistance arterioles, increase SVR) and venoconstriction (in capacitance vessels, increase preload); beta-1 receptors leading to tachycardia and increased contractility; and beta-2 receptors leading to bronchodilation; these actions are also helpful in severe allergic reactions (e.g. anaphylaxis) by stabilizing mast cells

21
Q

Epinephrine: Pharmacokinetics

A

Can be given iv (immediate), IM (variable), SC (5-15 min), and via inhalation (1-5 min onset), ophthalmic topical; metabolized by COMT and then renally excreted

22
Q

Epinephrine: Toxicity issues (contraindications, precautions, warnings, ADRs, etc)

A

Excessive vasoconstriction, HTN, hemorrhagic stroke, angina, arrhythmias

23
Q

Epinephrine: Drug interactions

A

Risk of excessive hypertension in patients taking propranolol

24
Q

Epinephrine: Special considerations

A
Utility with local anesthetics; drug of choice in severe
anaphylactic reactions (along with others)
25
Q

Epinephrine: Dose/route (not necessary to know)

A

For anaphylaxis, 0.1-0.5 mg SC or IM; for cardiac arrest, 1-5 mg IV push; for infusion, 1-4 mcg/min

26
Q

Epinephrine: Monitor

A

BP, HR, rhythm, infusion site, evidence of extravasation